9NOVEMBER 2025GOYAL DRIVES AMTZ MEDTECH PROGRESS WITH NEW LAUNCHESAccording to a senior business executive, state-owned electricity producer NTPC intends to establish nuclear power facilities with 700 MW, 1,000 MW, and 1,600 MW capacities across the nation.By 2047, NTPC hopes to have 30% (30 GW) of India's planned 100 GW nuclear capacity. According to industry estimates, a 1-GW nuclear facility takes at least three years from idea to commissioning and requires an investment of Rs 15,00020,000 crore.The official provided updates on the company's intentions for nuclear growth, stating that NTPC is now assessing land opportunities in a number of states, The Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam was visited by Piyush Goyal, the Hon'ble Union Minister of Commerce & Industry and Member of Parliament for North Mumbai, markinghistoric event in India's MedTech ecosystem.With more than 150 businesses that support research, engineering, and the creation of life-saving medical technology, AMTZ, which is spread across a vast 270-acre campus, has developed into one of the most extensive medical device manufacturing clusters in the world.The new Cathlab production facility of Innovation Imaging Technologies Pvt Ltd (IITPL) and 3i MedTech, a next-generation MRI manufacturing venture, were both launched by Piyush Goyal during his visit.India's audacious move toward independence in high-end diagnostic imaging equipment is symbolized by the including Andhra Pradesh, Gujarat, Madhya Pradesh, and Bihar."The capacities of the nuclear projects would be 700 MW, 1,000 MW and 1,600 MW," said the official who is involved in the company's strategic planning.In states designated and authorized by the Atomic Energy Regulatory Board (AERB), NTPC will move on with nuclear development."The AERB will approve the sites, and NTPC will accordingly implement the projects," the official added.Additionally, the corporation has started working on raw materials and is looking into purchasing uranium assets abroad.The main fuel utilized in nuclear reactors is uranium, a naturally occurring metallic element.A draft agreement for cooperative techno-commercial due diligence of uranium assets overseas has already been signed by NTPC and Uranium Corporation of India Ltd. (UCIL).In terms of technology, NTPC intends to use locally produced pressurized heavy-water reactors (PHWRs) for the 700 MW and 1,000 MW units. introduction of 3i MedTech. 3i MedTech was created in close cooperation with AMTZ with the goal of providing cutting-edge MRI solutions that are accurate, reasonably priced, and patient-centered.Simultaneously, the opening of IITPL's Cathlab manufacturing facility enhances India's capacity to manufacture advanced cardiac imaging technology at home, lowering reliance on imports and fostering domestic innovation.The increasing faith in India's capacity to generate top-notch healthcare solutions at scale is reinforced by these advances.Piyush Goyal commended Dr. Jitendra Sharma, the Managing Director and Founder CEO of AMTZ, for his visionary leadership in creating a globally competitive MedTech manufacturing environment during his interactions with industry executives and innovators on campus.The Minister praised AMTZ for its distinctive model that combines production speed, cost-effectiveness, and technological depth and expressed great confidence that India's MedTech sector is well positioned for fast growth. NTPC EYES 700­1600 MW NUCLEAR PLANTS ACROSS INDIA
< Page 8 | Page 10 >